Announced by Ministry of Health and the Ministry of Industry initiative for the introduction in Russia of mandatory labeling of packages containing drugs should improve the efficiency of public procurement – in the budget deficit, it will allow both to save money and to obtain accurate data on the use of soft pharmaceutical remedies. The Office will start an experiment on application of identification codes in 2017 – however, experts say that such work usually takes years and requires substantial expenditures, which is contrary to the logic of austerity.
The Ministry of Health is preparing a new system of control of public procurement of medicines that can start work from January 1, 2017, said Minister of Health Veronika Skvortsova. “We would like as part of public procurement to ensure a minimum deviation from the recommended price and such a way to ensure greater efficiency of public expenditure of resources,” – said the Minister. The first step will be to conduct an experiment in 2017 by marking the control marks of drugs – it said earlier the head of the Industry and Trade Denis Manturov, the government draft decree has already been posted on regulation.gov.ru portal. As stated in the explanatory memorandum, the Ministry of Health has prepared a document on behalf of the President on the results of the meeting of the government on the development and implementation of automated traffic monitoring system of medicines.
According to the document, the experiment needed to assess the effectiveness of the monitoring system of the future. She, in turn, will reduce the drug market share of counterfeit and smuggled goods and to reduce unfair competition. As part of the future of public procurement monitoring system should provide a common framework for accounting of supplies of drugs and their subsequent distribution.
In 2017, the Ministry of Health in the experiment will be attended by only a few companies that will be selected Roszdravnadzor this fall. Priority will be given to manufacturers of drugs for the treatment of blood cancer, hemophilia, cystic fibrosis and other rare diseases. On the packaging of their products are applied dimensional matrix Data Matrix code. Requirements for the encoding and the order of the information system the Ministry of Health will adopt the guidelines.
Earlier, similar systems have been developed for fur products and alcoholic products – the main reason for the introduction of labeling served as a substantial (in the case of fur products – up to 70%), the proportion of counterfeit goods on the market. But, according to Roszdravnadzor, the proportion of counterfeit medicines in Russia is minimal – so, for the first half of 2016 only 230 series products have been withdrawn from circulation. “In this case, the scale of the solution is not very consistent with the size of the problem to be solved”, – says CEO of DSM Group Sergey Shuljak.
On the other hand, taking into account the reduction of budget revenues and to limit its spending problem effectively integrate procurement of drugs will become increasingly important – but so far data on the use of significant amounts of drugs purchased on state funds, for other purposes not, says Mr. Shuljak. However, earlier on the need to collect data on the use of soft drugs Russians have said RANHiGS experts – their assessment in public procurement of medicines is often not possible to adequately determine the necessary amount of drugs, and some remains unclaimed purchased (see “Kommersant” on July 7.).
The technical component of the future of the project also makes experts question. “The international pharmaceutical industry is supported in principle the introduction of a monitoring system in Russia. At the same time, we understand that this is necessary to take into account a number of factors and, above all, of the technical solution mechanism, the establishment of appropriate terms of its study, taking into account the degree of readiness of all participants in the distribution chain, and also assess the economic costs and consequences “, – said” Y “head of the Association of international pharmaceutical manufacturers (AIMP) Vladimir Shipkov. According to him, in the world practice the realization of projects on creation of medicinal preparations required monitoring systems from 3 to 15 years depending on the scope and level of readiness of the participants. “Development of a monitoring system would require tens of billions of rubles of investments, but it is unlikely that the federal budget now there are funds”, – says David Melik-Guseinov, head of the Research Institute of Health Organization.
No comments:
Post a Comment